| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.07 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.07 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |